Independent Director · RHYTHM PHARMACEUTICALS, INC. (RYTM)

Chair, Nominating/Governance Committee

Stuart A. Arbuckle — RHYTHM PHARMACEUTICALS Director Compensation (2025)

Fiscal year 2025 director compensation for Stuart A. Arbuckle at RHYTHM PHARMACEUTICALS, INC.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

RHYTHM PHARMACEUTICALS Director Compensation Table · all 2 fiscal years held
In US dollars, as RHYTHM PHARMACEUTICALS reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$60,000$299,966$300,015$0$659,981
FY2024$61,333$165,560$398,782—$625,675

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 29, 2026, accession 0001628280-26-028375, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

RHYTHM PHARMACEUTICALS pays directors a $50,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Compensation · Nominating/Governance (Chair)

The rest of the RHYTHM PHARMACEUTICALS board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Christophe R. JeanIndependent Director$659,981
David P. MeekerChair of the Board$0
David W. J. McGirrIndependent Director$674,981
Jennifer GoodIndependent Director$659,981
Kimberly J. PopovitsIndependent Director$0
Lynn A. TetraultIndependent Director$669,981

The full RHYTHM PHARMACEUTICALS compensation record

free company brief

This page is one director within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy